Komipharm International Co., Ltd.

Komipharm International Co., Ltd.

041960.KQ
Komipharm International Co., Ltd.KR flagKOSDAQ
7,800.00
KRW
-100.00
- -
560.66BMarket Cap

Komipharm International Co., Ltd. (041960.KQ) Stock Split History

Learn about Komipharm International Co., Ltd.'s most recent 1100689-for-1000000 basis stock split on August 17, 2023. Understand the impact on shareholders and the company's market position.

APIChatGPT

Latest Stock Split Details

Key information about Komipharm International Co., Ltd.'s most recent stock split

Split Date: 2023-08-17
Split Ratio: 1100689:1000000
Price Before Split: $6273.93
Price After Split: $5700.00

Developer API

Get 041960.KQ split history as JSON

Dates, ratios, split factors, and pre/post-split prices from a single REST call. Look up by ticker, CIK, CUSIP, or ISIN. Free tier, no scraping.

GETapi.roic.ai/v2/stock-splits/041960.KQ

Impact of the Stock Split

Understanding what this means for shareholders

  • The total value of your investment remains the same
  • You now own 1.10 times more shares (a 1100689:1000000 ratio)
  • The price per share is reduced proportionally

Historical Stock Splits

A comprehensive history of Komipharm International Co., Ltd.'s stock splits

DateRatioIs Reverse SplitPrice Before SplitPrice After Split
2023-08-171100689:1000000No$6273.93$5700.00
2019-07-1111:10No$24364.99$22149.99
2018-12-2721:22Yes$13283.49$12679.69
2011-04-271000:231No$45783.40$10575.96
2007-12-2739803:192500Yes$349.52$72.27
2005-12-28105000:689587Yes$31.20$4.75
2004-12-291020000:7240663YesN/AN/A

About Komipharm International Co., Ltd.

Company overview and industry information

Komipharm International Co., Ltd. (041960.KQ) operates in the Medical - Pharmaceuticals industry. The recent 1100689-for-1000000 stock split reflects the company's growth and strategy to make shares more accessible to a broader range of investors.

Medical - Pharmaceuticals
Go to Komipharm International Co., Ltd. Summary

Last updated: 7/6/2026

This information is for educational purposes only. Always consult with a financial advisor before making investment decisions.